Sonia Okuyama Sasaki, MD

Associate Professor, Medicine

FacultyPhoto
Medical School
  • MD, Cayetano Heredia University
Residency
  • University of Texas Southwestern Medical School Program, Internal Medicine
Fellowships
  • University of Colorado, Hematology and Oncology
Languages
English, Spanish
Department
Medicine

Publications

  • Panse J, Daguindau N, Okuyama S, Peffault de Latour R, Schafhausen P, Straetmans N, Al-Adhami M, Persson E, Wong RSM. Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin =10 g/dL) who had received eculizumab or were naive to complement inhibitors. PLoS One. 2024;19(7):e0306407. PubMed PMID: 39079163
  • Feigelson HS, Mittendorf KF, Okuyama S, Porter KM, Bulkley J, Shuster E, Anderson KP, Gilmore MJ, Zepp JM, Kauffman TL, Lindberg NM, Muessig KR, Bellcross C, Ukaegbu C, Syngal S, Leo MC, Wilfond BS. Feasibility of an electronic patient-facing cancer family history tool in medically underserved populations. Genet Med Open. 2024;2:101860. PubMed PMID: 39669603
  • Brehany S, Colton M, Duarte C, Baliton M, McCranie AS, Okuyama S. Hereditary Cancer Screening and Outcomes at an Urban Safety-Net Hospital. JCO Precis Oncol. 2024 Jun;8:e2300699. PubMed PMID: 38935898
  • Borrayo EA, Juarez-Colunga E, Kilbourn K, Waxmonsky J, Jacobson M, Okuyama S, Swaney R, Wamboldt FS, Karam S, Lopez Alvarez S, Jin X, Nguyen J. Stepped-care to improve mental health outcomes among underserved patients with lung and head and neck cancer. Psychooncology. 2023 Nov;32(11):1718-1726. PubMed PMID: 37772984
  • Guo B, Knerr S, Kauffman TL, Mittendorf KF, Keast E, Gilmore MJ, Feigelson HS, Lynch FL, Muessig KR, Okuyama S, Zepp JM, Veenstra DL, Hsu L, Phipps AI, Lindström S, Leo MC, Goddard KAB, Wilfond BS, Devine B. Risk management actions following genetic testing in the Cancer Health Assessments Reaching Many (CHARM) Study: A prospective cohort study. Cancer Med. 2023 Sep;12(18):19112-19125. PubMed PMID: 37644850
  • Knerr S, Guo B, Wernli KJ, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Liles EG, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Wilfond BS, Devine B, Goddard KAB. Longitudinal adherence to breast cancer surveillance following cancer genetic testing in an integrated health care system. Breast Cancer Res Treat. 2023 Oct;201(3):461-470. PubMed PMID: 37470892
  • Okuyama S, White LL, Anderson KP, Medina E, Deutsch S, Ransom C, Jackson P, Kauffman TL, Mittendorf KF, Leo MC, Bulkley JE, Wilfond BS, Goddard KA, Feigelson HS. Evaluating cancer genetic services in a safety net system: overcoming barriers for a lasting impact beyond the CHARM research project. J Community Genet. 2023 Jun;14(3):329-336. PubMed PMID: 37126135
  • Lindberg NM, Mittendorf KF, Duenas DM, Anderson K, Koomas A, Kraft SA, Okuyama S, Shipman KJ, Vandermeer ML, Goddard KA, Wilfond BS, McMullen C. Engaging Patient Advisory Committees to Inform a Genomic Cancer Risk Study: Lessons for Future Efforts. Perm J. 2022 Jun 29;26(2):28-39. PubMed PMID: 35933674
  • Knerr S, Guo B, Mittendorf KF, Feigelson HS, Gilmore MJ, Jarvik GP, Kauffman TL, Keast E, Lynch FL, Muessig KR, Okuyama S, Veenstra DL, Zepp JM, Goddard KAB, Devine B. Risk-reducing surgery in unaffected individuals receiving cancer genetic testing in an integrated health care system. Cancer. 2022 Aug 15;128(16):3090-3098. PubMed PMID: 35679147
  • Amendola LM, Shuster E, Leo MC, Dorschner MO, Rolf BA, Shirts BH, Gilmore MJ, Okuyama S, Zepp JM, Kauffman TL, Mittendorf KF, Bellcross C, Jenkins CL, Joseph G, Riddle L, Syngal S, Ukaegbu C, Goddard KAB, Wilfond BS, Jarvik GP. Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access. Genet Med. 2022 Jun;24(6):1196-1205. PubMed PMID: 35305866
  • Mittendorf KF, Kauffman TL, Amendola LM, Anderson KP, Biesecker BB, Dorschner MO, Duenas DM, Eubanks DJ, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Lee SSJ, Leo MC, Liles EG, Lindberg NM, Muessig KR, Okuyama S, Porter KM, Riddle LS, Rolf BA, Rope AF, Zepp JM, Jarvik GP, Wilfond BS, Goddard KAB. Corrigendum to "Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations" [Contemporary Clinical Trials 106 (2021) 106432]. Contemp Clin Trials. 2022 Mar;114:106682. PubMed PMID: 35123916
  • Gutierrez AM, Robinson JO, Outram SM, Smith HS, Kraft SA, Donohue KE, Biesecker BB, Brothers KB, Chen F, Hailu B, Hindorff LA, Hoban H, Hsu RL, Knight SJ, Koenig BA, Lewis KL, Lich KH, O'Daniel JM, Okuyama S, Tomlinson GE, Waltz M, Wilfond BS, Ackerman SL, Majumder MA. Examining access to care in clinical genomic research and medicine: Experiences from the CSER Consortium. J Clin Transl Sci. 2021;5(1):e193. PubMed PMID: 34888063
  • Mittendorf KF, Kauffman TL, Amendola LM, Anderson KP, Biesecker BB, Dorschner MO, Duenas DM, Eubanks DJ, Feigelson HS, Gilmore MJ, Hunter JE, Joseph G, Kraft SA, Lee SSJ, Leo MC, Liles EG, Lindberg NM, Muessig KR, Okuyama S, Porter KM, Riddle LS, Rolf BA, Rope AF, Zepp JM, Jarvik GP, Wilfond BS, Goddard KAB. Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations. Contemp Clin Trials. 2021 Jul;106:106432. PubMed PMID: 33984519
  • Mittendorf KF, Ukaegbu C, Gilmore MJ, Lindberg NM, Kauffman TL, Eubanks DJ, Shuster E, Allen J, McMullen C, Feigelson HS, Anderson KP, Leo MC, Hunter JE, Sasaki SO, Zepp JM, Syngal S, Wilfond BS, Goddard KAB. Adaptation and early implementation of the PREdiction model for gene mutations (PREMM(5)™) for lynch syndrome risk assessment in a diverse population. Fam Cancer. 2021 Mar 23. [Epub ahead of print] PubMed PMID: 33754278
  • Amendola, Rofl, Shuster, Mittendorf, Kauffman, Anderson, Okuyama, Goddard, Wilfond, Sorschner, Jarvik. “Results from clinical exome sequencing for cancer risk assessment in primary care patients who screen positive for genetic risk”. Poster presentation. American Society of Human Genetics 2019 Annual meeting. October 2019.
  • Grant C, Vandyke G, Okuyama S. “Development of the Outpatient Oral Antineoplastic Adeherence Monitoring Program at Denver Health” Poster presented at Denver Health Days of Celebration, June 2019.
  • Kauffman, Goddard, Hunter, Leo, Reyes, Arnold, Schield, Eubanks, Allen, Shuster, Jarvik, Anderson, Okuyama, Deutsch, Rodriguez, Medina, Wilfond. “Increasing Access to Genomic Services across Underserved Populations: An Online Approach to Identify and Consent High Risk Individuals” Poster presentation. 2019 American College of Medical Genetics and Genomics (ACMG) Clinical Genetics Meeting: April 2019.
  • Fiegelson, Mittendorf, Kauffman, Anderson, Okuyama, Wilfond, Jarvik, Amendola, McMullen, Lynch, Eubanks, Shuster, Allen, Kraft, Joseph, Lee, Goddard. “Using Web-based Tools to Assess Familial Cancer Risk in Diverse Populations”. Poster and Oral presentation. American Association for Cancer Research (AACR) Annual Meeting. February 2019.
  • Hawkins KL, Hoffman M, Okuyama S, Rowan SE. A Case of Fulminant Meningococcemia: It Is All in the Complement. Case Rep Infect Dis. 2017;2017:6093695. PubMed PMID: 28808592
  • Fischer SM, Kline DM, Min SJ, Okuyama S, Fink RM. Apoyo con Cariño: Strategies to Promote Recruiting, Enrolling, and Retaining Latinos in a Cancer Clinical Trial. J Natl Compr Canc Netw. 2017 Nov;15(11):1392-1399. PubMed PMID: 29118231

Professional Memberships

  • American Society of Clinical Oncology, Full Member

Practice Locations

Denver Health
777 Bannock St
Denver, CO 80204
303-436-6000

Hospital Affiliation
  • Denver Health Medical Center

Specialty Information

Specialties
  • Internal Medicine, Board Certification
  • Medical Oncology, Board Certification

School of Medicine

CU Anschutz
Fitzsimons Building

13001 East 17th Place

Aurora, CO 80045

303.724.5375

School
General
Students